Report Detail
Global Covid-19 Treatment Medicine Market Growth 2022-2028
- RnM4481431 |
- 10 August, 2022 |
- Global |
- 97 Pages |
- LPI(LP Information) |
- Technology
As the global economy mends, the 2021 growth of Covid-19 Treatment Medicine will have significant change from previous year. According to our (LP Information) latest study, the global Covid-19 Treatment Medicine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Covid-19 Treatment Medicine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Covid-19 Treatment Medicine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Covid-19 Treatment Medicine market, reaching US$ million by the year 2028. As for the Europe Covid-19 Treatment Medicine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Covid-19 Treatment Medicine players cover Pfizer (Paxlovid), VEKLURY (Remdesivir), Lagevrio, and GSK (Sotrovimab), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Covid-19 Treatment Medicine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Oral
Injetion
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Mild-to-Moderate COVID-19
Severe Patient
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer (Paxlovid)
VEKLURY (Remdesivir)
Lagevrio
GSK (Sotrovimab)
Regeneron (Ronapreve)
Yiling Pharmaceutical
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Covid-19 Treatment Medicine Annual Sales 2017-2028
- 2.1.2 World Current & Future Analysis for Covid-19 Treatment Medicine by Geographic Region, 2017, 2022 & 2028
- 2.1.3 World Current & Future Analysis for Covid-19 Treatment Medicine by Country/Region, 2017, 2022 & 2028
- 2.2 Covid-19 Treatment Medicine Segment by Type
- 2.2.1 Oral
- 2.2.2 Injetion
- 2.3 Covid-19 Treatment Medicine Sales by Type
- 2.3.1 Global Covid-19 Treatment Medicine Sales Market Share by Type (2017-2022)
- 2.3.2 Global Covid-19 Treatment Medicine Revenue and Market Share by Type (2017-2022)
- 2.3.3 Global Covid-19 Treatment Medicine Sale Price by Type (2017-2022)
- 2.4 Covid-19 Treatment Medicine Segment by Application
- 2.4.1 Mild-to-Moderate COVID-19
- 2.4.2 Severe Patient
- 2.5 Covid-19 Treatment Medicine Sales by Application
- 2.5.1 Global Covid-19 Treatment Medicine Sale Market Share by Application (2017-2022)
- 2.5.2 Global Covid-19 Treatment Medicine Revenue and Market Share by Application (2017-2022)
- 2.5.3 Global Covid-19 Treatment Medicine Sale Price by Application (2017-2022)
3 Global Covid-19 Treatment Medicine by Company
- 3.1 Global Covid-19 Treatment Medicine Breakdown Data by Company
- 3.1.1 Global Covid-19 Treatment Medicine Annual Sales by Company (2020-2022)
- 3.1.2 Global Covid-19 Treatment Medicine Sales Market Share by Company (2020-2022)
- 3.2 Global Covid-19 Treatment Medicine Annual Revenue by Company (2020-2022)
- 3.2.1 Global Covid-19 Treatment Medicine Revenue by Company (2020-2022)
- 3.2.2 Global Covid-19 Treatment Medicine Revenue Market Share by Company (2020-2022)
- 3.3 Global Covid-19 Treatment Medicine Sale Price by Company
- 3.4 Key Manufacturers Covid-19 Treatment Medicine Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Covid-19 Treatment Medicine Product Location Distribution
- 3.4.2 Players Covid-19 Treatment Medicine Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Covid-19 Treatment Medicine by Geographic Region
- 4.1 World Historic Covid-19 Treatment Medicine Market Size by Geographic Region (2017-2022)
- 4.1.1 Global Covid-19 Treatment Medicine Annual Sales by Geographic Region (2017-2022)
- 4.1.2 Global Covid-19 Treatment Medicine Annual Revenue by Geographic Region
- 4.2 World Historic Covid-19 Treatment Medicine Market Size by Country/Region (2017-2022)
- 4.2.1 Global Covid-19 Treatment Medicine Annual Sales by Country/Region (2017-2022)
- 4.2.2 Global Covid-19 Treatment Medicine Annual Revenue by Country/Region
- 4.3 Americas Covid-19 Treatment Medicine Sales Growth
- 4.4 APAC Covid-19 Treatment Medicine Sales Growth
- 4.5 Europe Covid-19 Treatment Medicine Sales Growth
- 4.6 Middle East & Africa Covid-19 Treatment Medicine Sales Growth
5 Americas
- 5.1 Americas Covid-19 Treatment Medicine Sales by Country
- 5.1.1 Americas Covid-19 Treatment Medicine Sales by Country (2017-2022)
- 5.1.2 Americas Covid-19 Treatment Medicine Revenue by Country (2017-2022)
- 5.2 Americas Covid-19 Treatment Medicine Sales by Type
- 5.3 Americas Covid-19 Treatment Medicine Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Covid-19 Treatment Medicine Sales by Region
- 6.1.1 APAC Covid-19 Treatment Medicine Sales by Region (2017-2022)
- 6.1.2 APAC Covid-19 Treatment Medicine Revenue by Region (2017-2022)
- 6.2 APAC Covid-19 Treatment Medicine Sales by Type
- 6.3 APAC Covid-19 Treatment Medicine Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
7 Europe
- 7.1 Europe Covid-19 Treatment Medicine by Country
- 7.1.1 Europe Covid-19 Treatment Medicine Sales by Country (2017-2022)
- 7.1.2 Europe Covid-19 Treatment Medicine Revenue by Country (2017-2022)
- 7.2 Europe Covid-19 Treatment Medicine Sales by Type
- 7.3 Europe Covid-19 Treatment Medicine Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Covid-19 Treatment Medicine by Country
- 8.1.1 Middle East & Africa Covid-19 Treatment Medicine Sales by Country (2017-2022)
- 8.1.2 Middle East & Africa Covid-19 Treatment Medicine Revenue by Country (2017-2022)
- 8.2 Middle East & Africa Covid-19 Treatment Medicine Sales by Type
- 8.3 Middle East & Africa Covid-19 Treatment Medicine Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Covid-19 Treatment Medicine
- 10.3 Manufacturing Process Analysis of Covid-19 Treatment Medicine
- 10.4 Industry Chain Structure of Covid-19 Treatment Medicine
11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Covid-19 Treatment Medicine Distributors
- 11.3 Covid-19 Treatment Medicine Customer
12 World Forecast Review for Covid-19 Treatment Medicine by Geographic Region
- 12.1 Global Covid-19 Treatment Medicine Market Size Forecast by Region
- 12.1.1 Global Covid-19 Treatment Medicine Forecast by Region (2023-2028)
- 12.1.2 Global Covid-19 Treatment Medicine Annual Revenue Forecast by Region (2023-2028)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Covid-19 Treatment Medicine Forecast by Type
- 12.7 Global Covid-19 Treatment Medicine Forecast by Application
13 Key Players Analysis
- 13.1 Pfizer (Paxlovid)
- 13.1.1 Pfizer (Paxlovid) Company Information
- 13.1.2 Pfizer (Paxlovid) Covid-19 Treatment Medicine Product Offered
- 13.1.3 Pfizer (Paxlovid) Covid-19 Treatment Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.1.4 Pfizer (Paxlovid) Main Business Overview
- 13.1.5 Pfizer (Paxlovid) Latest Developments
- 13.2 VEKLURY (Remdesivir)
- 13.2.1 VEKLURY (Remdesivir) Company Information
- 13.2.2 VEKLURY (Remdesivir) Covid-19 Treatment Medicine Product Offered
- 13.2.3 VEKLURY (Remdesivir) Covid-19 Treatment Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.2.4 VEKLURY (Remdesivir) Main Business Overview
- 13.2.5 VEKLURY (Remdesivir) Latest Developments
- 13.3 Lagevrio
- 13.3.1 Lagevrio Company Information
- 13.3.2 Lagevrio Covid-19 Treatment Medicine Product Offered
- 13.3.3 Lagevrio Covid-19 Treatment Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.3.4 Lagevrio Main Business Overview
- 13.3.5 Lagevrio Latest Developments
- 13.4 GSK (Sotrovimab)
- 13.4.1 GSK (Sotrovimab) Company Information
- 13.4.2 GSK (Sotrovimab) Covid-19 Treatment Medicine Product Offered
- 13.4.3 GSK (Sotrovimab) Covid-19 Treatment Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.4.4 GSK (Sotrovimab) Main Business Overview
- 13.4.5 GSK (Sotrovimab) Latest Developments
- 13.5 Regeneron (Ronapreve)
- 13.5.1 Regeneron (Ronapreve) Company Information
- 13.5.2 Regeneron (Ronapreve) Covid-19 Treatment Medicine Product Offered
- 13.5.3 Regeneron (Ronapreve) Covid-19 Treatment Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.5.4 Regeneron (Ronapreve) Main Business Overview
- 13.5.5 Regeneron (Ronapreve) Latest Developments
- 13.6 Yiling Pharmaceutical
- 13.6.1 Yiling Pharmaceutical Company Information
- 13.6.2 Yiling Pharmaceutical Covid-19 Treatment Medicine Product Offered
- 13.6.3 Yiling Pharmaceutical Covid-19 Treatment Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.6.4 Yiling Pharmaceutical Main Business Overview
- 13.6.5 Yiling Pharmaceutical Latest Developments
14 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Covid-19 Treatment Medicine. Industry analysis & Market Report on Covid-19 Treatment Medicine is a syndicated market report, published as Global Covid-19 Treatment Medicine Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Covid-19 Treatment Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
